Atlas Trials

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

Clinical trial NCT00436540 · COMPLETED

Trial details

NCT number
NCT00436540
Sponsor
Galderma R&D
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Psoriasis
Start date
2006-03-01
Primary completion
2007-01-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.